Area of research
Epidemiology · Hepatology
Research interest
Research interests include Cancer research, Biology, Medicine, Fatty liver, Alcoholic liver disease, and Hepatic stellate cell.
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
The spleen-liver axis supports obesity-induced systemic and fatty liver inflammation via MDSC and NKT cell enrichment
The liver talks back: NPY orchestrates attraction of cancer cells and CHK2-dependent clonogenicity in the metastatic niche
Gut Pathobiont–Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in Primary Sclerosing Cholangitis–Associated Inflammatory Bowel Disease
Sex-Dependent T Cell Dysregulation in Mice with Diet-Induced Obesity
Colocalization analysis of pancreas eQTLs with risk loci from alcoholic and novel non-alcoholic chronic pancreatitis GWAS suggests potential disease causing mechanisms
Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
Association of Rare <i>CYP39A1</i> Variants With Exfoliation Syndrome Involving the Anterior Chamber of the Eye
Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11
Gender differences in Western-type diet-induced alterations of lipid metabolisms in the liver and adipose tissue of mice
Pharmacological Inhibition of mTORC2 Reduces Migration and Metastasis in Melanoma
BMP-9 Modulates the Hepatic Responses to LPS
Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury
Expression and Function of Four-and-a-Half LIM-domain protein 2 (FHL2) in Hepatic Fibrosis
Deficient IL‐6/Stat3 Signaling, High TLR7, and Type I Interferons in Early Human Alcoholic Liver Disease: A Triad for Liver Damage and Fibrosis
Heterozygous carriage of the alpha1-antitrypsin Pi*Z variant increases the risk to develop liver cirrhosis
Micro<scp>RNA</scp>‐622 is a novel mediator of tumorigenicity in melanoma by targeting Kirsten rat sarcoma
The role of mechanistic target of rapamycin complex 2-component RICTOR in hepatocellular carcinoma progression and sorafenib-resistance
Intestinal fungi contribute to development of alcoholic liver disease
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Genome-wide association study identifies inversion in the <i>CTRB1-CTRB2</i> locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis
Wild-type KRAS is a novel therapeutic target for melanoma contributing to primary and acquired resistance to BRAF inhibition
Immunometabolic Determinants of Chemoradiotherapy Response and Survival in Head and Neck Squamous Cell Carcinoma
An iso-α-acid-rich extract from hops ( Humulus lupulus ) attenuates acute alcohol-induced liver steatosis in mice
Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues From Patients
The potential of silymarin for the treatment of hepatic disorders
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis
S2k-Leitlinie nicht alkoholische Fettlebererkrankungen
[S2k Guideline non-alcoholic fatty liver disease].
Ferritin-Mediated Iron Sequestration Stabilizes Hypoxia-Inducible Factor-1α upon LPS Activation in the Presence of Ample Oxygen